2021 Archive

Learn what associate scientist Anand Kulkarni, PhD, thinks makes doing research at St. Jude different from anywhere else.

St. Jude is leading a global clinical trial for brain tumors.

Meet postdoctoral researcher Janeala Morsby, PhD, Department of Oncology and learn about her research.

Learn what patients, families and health care workers think about gene therapy.

Meet postdoctoral researcher Priyanka Dogra, PhD, Department of Structural Biology, and learn about her research.  

Find how sickle cell treatment may help kids get better sleep.

Meet postdoctoral researcher Maowei Hu, PhD, Department of Chemical Biology & Therapeutics and learn about her research.  

Explore innovative research and clinical care milestones in pediatric leukemias, sickle cell disease, HIV, radiation oncology and cancer genomics from the past six decades at St. Jude.

See how a collaborative effort in proteomics produced a comprehensive turnover atlas and sparked discovery in Alzheimer’s disease research.

Venkatraman Radhakrishnan MD, MS, led the creation of India’s first childhood cancer registry to improve data collection and care in resource-limited regions.

The National Comprehensive Cancer Network recently published treatment guidelines for children diagnosed with nephroblastoma. Two St. Jude physicians collaborated on the project.

As cancer survivorship changes, new benchmarks must be set to redefine survivorship research and treatment success.

It’s essential to provide an accurate, science-based website for vaccine information. The St. Jude Global COVID-19 Working Group plans to provide accurate COVID-19 information, including answering questions and providing vaccine news as it emerges.

St. Jude Children’s Research Hospital is launching the largest strategic investment in its nearly 60-year history, committing $11.5 billion during the next six years to accelerate research and treatment globally for children with catastrophic diseases.

Cancer treatments can result in damage to the heart both during treatment and years following completion of therapy. As many cancer survivors are now living longer into adulthood, we’re gaining a better understanding of some of the late effects of cancer treatments that we weren’t able to observe before.

Scientists are learning more about antibody production in response to flu, including how they develop from helper T cells and monocytes.

The pandemic exposed shortcomings in health care. But this study revealed more than expected in this type of children’s treatment.

Tangie Thomas, MPH, is vice president of Clinical Trials Operations at St. Jude Children’s Research Hospital.

For Jasmine Turner, resilience and tenacity were required to enter a field with very few Black women. There weren’t many women or teachers of color in her scientific courses—no one with similar experiences to help guide her or focus her talents. She turned to her mother for encouragement and inspiration.

This study, to our knowledge, is the first to objectively measure hearing and neurocognitive function in a large cohort of long-term survivors of childhood cancer stratified by treatment exposures.